OTC: LBTSF - Almirall, S.A.

Lønnsomhet i seks måneder: -3.54%
Utbytte: 0.00%
Sektor: Healthcare

Kampanjeplan Almirall, S.A.


Om selskapet Almirall, S.A.

Almirall, S.A., a biopharmaceutical company, engages in the research, development, manufacture, and sale of skin-health related medicines in Europe, the United States, and internationally.

flere detaljer
The company offers its products for dermatological diseases comprising actinic keratosis, atopic dermatitis, androgenic alopecia, psoriasis, onychomycosis, oncodermatology, acne, and orphan indications, as well as for cardiovascular, musculo-skeletal, respiratory, and nervous system; alimentary tract and metabolism; antiinfectives for systemic use; genito urinary system and sex hormones; immunostimulants; and systematic hormonal preparations. Its products include Ilumetri, Solaraze, Actikerall, Ciclopoli, Skilarence, Aczone, Decoderm, Cordran Tape, Azelex, Klisyri, Tazorac, Seysara, Veltin, Almax, Ebastel, Sativex, Crestor, and Efficib/Tesavel. Almirall, S.A. has collaboration and partnership agreements with Tyris Therapeutics, BIOMAP, the University of Dundee, Kaken Pharmaceutical Co Ltd., Ichnos Sciences Inc., the University Carlos III Madrid and MEDINA Foundation, 23andMe, Inc., HitGen Ltd., WuXi Biologics, Eli Lilly and Company, and Athenex, Inc. The company was formerly known as Laboratorios Almirall, S.A. and changed its name to Almirall, S.A. in May 2009. Almirall, S.A. was founded in 1943 and is headquartered in Barcelona, Spain.

Industry Pharmaceuticals
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 2.11
Дивиденд ао 0.1873
Сайт https://www.almirall.com
Цена ао 9.51
Prisendring per dag: 0% (9.173)
Prisendring per uke: 0% (9.173)
Prisendring per måned: 0% (9.173)
Prisendring over 3 måneder: -3.54% (9.51)
Prisendring over seks måneder: -3.54% (9.51)
Prisendring per år: +0.8022% (9.1)
Prisendring over 3 år: 0% (9.173)
Prisendring over 5 år: 0% (9.173)
Prisendring over 10 år: 0% (9.173)
Prisendring siden begynnelsen av året: 0% (9.173)

Undervurdering

Navn Betydning Karakter
P/S 1.81 8
P/BV 1.23 9
P/E 384.08 1
EV/EBITDA 9.79 8
Total: 5.88

Effektivitet

Navn Betydning Karakter
ROA, % -1.79 0
ROE, % -2.91 0
Total: 1.17

Utbytte

Navn Betydning Karakter
Div yield, % 0 0
DSI 0.7143 7.14
Total: 3.25

Plikt

Navn Betydning Karakter
Debt/EBITDA 1.98 7
Total: 9.4

Vekstimpuls

Navn Betydning Karakter
Lønnsomhet Revenue, % 13.53 2
Lønnsomhet Ebitda, % -56.04 0
Lønnsomhet EPS, % -137.83 0
Total: 0.4



Veileder Stillingstittel Betaling Fødselsår
Mr. Carlos Gallardo Piqué CEO, President, Member of Management Board & Chairman of the Board 53.55k 1972 (53 år)
Mr. Michael McClellan CFO & Member of Management Board N/A 1972 (53 år)
Mr. Eloi Crespo Cervera Chief Industrial Operations Officer & Member of Management Board N/A
Mr. Esteve Conesa Panicot Chief People & Culture Officer and Member of Management Board N/A
Dr. Volker Koscielny Chief Medical Officer & Member of Management Board N/A
Dr. Karl Ziegelbauer Chief Scientific Officer & Member of Management Board N/A
Mr. Paolo Cionini Chief Commercial Officer Europe & International and Member of Management Board N/A
Ms. Isabel Cristina Gomes Company Vice Secretary,Chief Legal Officer, General Counsel & Member of Management Board N/A
Ms. Mercedes Diz Lopez Chief Marketing Officer & Member of Management Board N/A
Mr. Pablo Divasson del Fraile Senior Director of Investor Relations N/A

Adresse: Spain, Barcelona, Ronda General Mitre. 151 - åpne i Google maps, åpne Yandex-kart
Nettsted: https://www.almirall.com